This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

Delisting of Horizon Therapeutics Ireland DAC

03 November 2023

Hamilton, Bermuda:  November 3, 2023Horizon Therapeutics Ireland DAC (the “Company”) has advised the Bermuda Stock Exchange (the BSX) of the maturity and redemption of the following securities listed on the BSX:


·         Horizon Therapeutics Ireland DAC - 6.9% Promissory Note due December 31, 2029


The de-listing of the securities from the BSX pursuant to the provisions of the BSX Listing Regulations, Section I, Chapter 2, Regulation 2.33 is effective today, November 3, 2022.



# # # #


About BSX

The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit or contact


Disclaimer and Privacy Policy    Complaints Policy

Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!

Questions or requests for information can be emailed to